Clinical Trial Update: Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients [Phase 4]

View source ↗

Summary

This Phase 4 trial compared boosted atazanavir with ritonavir versus non-boosted atazanavir in ART-naive HIV patients and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir) (ritonavir)
• Reyataz (atazanavir) (atazanavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 4 | Status: COMPLETED